Tumor heterogeneity confounds and illuminates: assessing the implications, Nat Med, vol.20, pp.342-346, 2014. ,
,
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution, Cancer Cell, vol.27, pp.15-26, 2015. ,
,
CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations, Mol Cell, vol.63, pp.526-564, 2016. ,
Genome editing. The new frontier of genome engineering with CRISPR-Cas9, Science, vol.346, p.1258096, 2014. ,
,
Development and applications of CRISPR-Cas9 for genome engineering, Cell, vol.157, pp.1262-78, 2014. ,
, , p.24906146
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells, Nat Biotechnol, vol.31, pp.822-828, 2013. ,
,
Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease, Nat Bio, vol.32, pp.677-83, 2014. ,
Genome engineering using the CRISPR-Cas9 system, Nat Protocols, vol.8, pp.2281-308, 2013. ,
,
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding, Nat Med, vol.21, pp.440-448, 2015. ,
Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells, Nature, vol.528, pp.267-71, 2015. ,